logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
J

Jacob P. Laubach

Harvard Medical School
H指数:63
被引数:1.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Macrophage reprogramming, not CD8 T cell dynamics, characterizes durable disease control following PD-1 blockade in smoldering myeloma

巨噬细胞重编程，而非CD8 T细胞动力学，是PD-1阻断后冒烟性骨髓瘤获得持久疾病控制的特点

Leukemia
IF13.4
2026-09-030
PRE
Noé Perron; Kane Foster; Tarek H. Mouhieddine; Robert A. Redd; Sophie Magidson; Jacqueline Perry; Ashlee Sturtevant; Christine Davie; Caroline Ricciardi; Frances Arters; Marjorie Marto; Amy Goguen; Yuxin Liu; Elizabeth K. O’Donnell; Adam S. Sperling; Jacob P. Laubach; Paul G. Richardson; Gad Getz; Romanos Sklavenitis-Pistofidis; Lorenzo Trippa; Yoshinobu Konishi; Omar Nadeem; Irene M. Ghobrial
FcRH5×CD3 bispecific antibody cevostamab in relapsed or refractory multiple myeloma: a phase 1 trial

FcRH5×CD3双特异性抗体塞沃司单抗在复发或难治性多发性骨髓瘤中的应用：一项I期临床试验

Nature Medicine
IF50
2026-07-220
OAAI
Adam D. Cohen; Joshua Richter; Suzanne Trudel; Alexander Lesokhin; Jacob P. Laubach; Sheeba K. Thomas; Simon J. Harrison; Luciano J. Costa; Andrew Spencer; Rafael Fonseca; Peter A. Forsberg; Jesus G. Berdeja; Rayan Kaedbey; Nizar J. Bahlis; Paula Rodriguez-Otero; Maria-Victoria Mateos; Tulika Tyagi; Divya Samineni; Wenyu Liu; Rin Nakamura; Voleak Choeurng; Chihunt Wong; James Cooper; Amrita Krishnan
Isatuximab: an anti-CD38 therapy that addresses unmet needs and mechanisms of resistance in multiple myeloma

伊沙妥昔单抗：一种针对多发性骨髓瘤中未满足需求及耐药机制的抗CD38疗法

Expert Opinion on Investigational Drugs
IF4.1
2026-05-040
PRE
Yuxin Liu; Clifton Mo; Shonali Midha; Monique Hartley-Brown; Hans C. Lee; Joseph Franz; Omar Nadeem; Taylor Nicholson; Taya Jamal Salman; Anne Fortune; Robert Rifkin; Lauren E. Merz; Jesus Berdeja; Jacob Laubach; Peter O’Gorman; Paul G. Richardson
A review of the clinical efficacy of monoclonal antibody (mAb)-based therapies for relapsed/refractory multiple myeloma (RRMM)

单克隆抗体（mAb）为基础的疗法治疗复发/难治性多发性骨髓瘤（RRMM）的临床疗效综述

Expert Opinion on Biological Therapy
IF4
2026-04-050
PRE
Yuxin Liu; Ji Hyun Lee; Clifton C. Mo; Taya Jamal Salman; Shahrier Hossain; Shonali Midha; Omar Nadeem; Taylor Nicholson; Jessica Croteau; Natalie Kazierad; Tarek H. Mouhieddine; Poy Theprungsirikul; Jacob P. Laubach; Paul G. Richardson
A clonally expanded nodal T-cell population diagnosed as T-cell lymphoma after CAR-T therapy

CAR-T治疗后被诊断为T细胞淋巴瘤的克隆性扩增的淋巴结T细胞群体

Nature Communications
IF15.7
2025-08-120
OA
Katie Maurer; Jackson A. Weir; Adi Nagler; Nicholas J. Haradhvala; Hariharan Bharadwaj; Jacob Shapiro; Somkene Alakwe; Vipin Kumar; Brianna Waller; Mikaela McDonough; Jamie Dela Cruz; Loida Luna; Emma Lin; Linsey Gong; Qiyu Gong; Mehdi Borji; Phillip D. Michaels; Jacob P. Laubach; Geraldine Pinkus; Gad Getz; Catherine J. Wu; Fei Chen; Caron Jacobson
Isatuximab for the treatment of multiple myeloma: current clinical advances and future directions

Isatuximab在多发性骨髓瘤治疗中的应用：当前临床进展与未来方向

Expert Opinion on Investigational Drugs
IF4.1
2025-07-230
OA
Paul G. Richardson; Elisabeth K. O’Donnell; Peter O’Gorman; Lisa B. Leypoldt; Jacob Laubach; Francesca Gay; Xavier Leleu; Thierry Facon; Philippe Moreau; Meletios A. Dimopoulos; Hartmut Goldschmidt; Elias K. Mai; Michele Cavo; Katja C. Weisel; Jesus G. Berdeja; Robert Z. Orlowski; Meral Beksaç; Aurore Perrot; Joseph Mikhael; Thomas Martin
Psychosocial and NF-κB Activity Effects of the Stress Management and Resiliency Training: Relaxation Response Resiliency Program (SMART-3RP) on Patients With MGUS and Smoldering Multiple Myeloma: A Randomized Waitlist Control Trial

心理社会和NF-κB活性：压力管理与韧性训练（放松反应韧性计划，SMART-3RP）对MGUS和冒烟型多发性骨髓瘤患者的影响：一项随机等待列表对照试验

Psycho-Oncology
IF3.5
2025-07-180
PRE
Lucy Finkelstein-Fox; John W. Denninger; Leah E. Walsh; Jacob P. Laubach; Andrew Jenho Yee; Elizabeth O'Donnell; Eric A. Macklin; Xuesong Gu; Alona Muzikansky; Towia A. Libermann; Gabriella Nicolosi; Paul G. Richardson; Noopur S. Raje; Gregory L. Fricchione; Giselle K. Perez; Lara N. Traeger; Emma Chad-Friedman; Elyse R. Park
Single-cell and clonal analysis of AL amyloidosis plasma cells and their bone marrow microenvironment

单细胞和克隆分析AL淀粉样变性浆细胞及其骨髓微环境

Blood
IF23.1
2025-06-160
PRE
Nicolas A. Gort-Freitas; Maria Moscvin; Matteo C. Da Vià; Francesca Lazzaroni; Alice Nevone; Sam Sadigh; Samuel Boullt; Benjamin Evans; Tianzeng Chen; Tanya Karagiannis; Albert Tai; Sean Rowell; Srinidhi Raghav; Antonia F. Chen; Jacob P. Laubach; Caitlin Edwards; Jon C. Aster; Zizhang Sheng; Joao A. Paulo; Chi N. Chan; Mario Nuvolone; Niccolò Bolli; Raymond L. Comenzo; Allon M. Klein; Giada Bianchi
Prospective study of immunogenicity to SARS-CoV-2 booster vaccines in multiple myeloma and Waldenström macroglobulinemia

多发性骨髓瘤和Waldenström巨球蛋白血症患者对SARS-CoV-2加强疫苗免疫原性的前瞻性研究

Blood Advances
IF7.1
2025-06-090
OAAI
Andrew R. Branagan; Clifton Mo; Matthew Lei; Joshua N. Gustine; Andrew J. Yee; Elizabeth O’Donnell; Jorge J. Castillo; Omar Nadeem; Catherine Flynn; Zachary Bernstein; Rie Nakamoto-Matsubara; Kirsten Meid; Rakesh Verma; Zachary R. Hunter; Maria L. Guerrera; Galit Alter; Jill Burke; Cynthia Harrington; Emerentia Agyemang; Marilyn Gammon; Kathleen Lively; Lisette Packer; Nora Horick; Jacob Laubach; Constantine S. Mitsiades; Nikhil Munshi; Kenneth C. Anderson; Steven P. Treon; Paul G. Richardson; Noopur S. Raje; Shayna R. Sarosiek
Daratumumab for newly diagnosed multiple myeloma: Pooled analysis of patients aged ≥65 years from GRIFFIN and PERSEUS

达鲁atumumab用于 newly diagnosed multiple myeloma：来自GRIFFIN和PERSEUS研究中≥65岁患者的合并分析

Clinical Lymphoma Myeloma and Leukemia
IF2.7
2025-04-110
PREAI
Paula Rodriguez-Otero; Peter M. Voorhees; Mario Boccadoro; Jacob Laubach; Hermann Einsele; Douglas W. Sborov; Meletios A. Dimopoulos; Annemiek Broijl; Roberto Mina; Andrew Spencer; Fredrik Schjesvold; Rebecca Silbermann; Francesca Gay; Luciano J. Costa; Aurore Perrot; Yanfang Liu; Jianping Wang; Anna Sitthi-Amorn; Robin Carson; Annelore Cortoos; Saad Z. Usmani; Paul G. Richardson; Philippe Moreau; Pieter Sonneveld; Jonathan L. Kaufman
Outcomes of Patients By High-Risk Cytogenetic Abnormalities in a Phase II Study of Isatuximab, Weekly Carfilzomib, Lenalidomide, Dexamethasone in Newly Diagnosed, Multiple Myeloma (The SKylaRk Trial) Who Deferred Transplant

伊沙妥昔单抗、每周卡非佐米、来那度胺、地塞米松方案在初诊多发性骨髓瘤患者（SKylaRk试验）中，因延迟移植的高风险细胞遗传学异常患者的结局

BLOOD
IF23.1
2024-11-051
PRE
O'Donnell, Elizabeth K.; Mo, Clifton C.; Nadeem, Omar; Laubach, Jacob; Rosenblatt, Jacalyn; Munshi, Nikhil C.; Midha, Shonali; Cirstea, Diana; Richardson, Paul G.; Raje, Noopur; Yee, Andrew J.
A plain language summary of the final analysis of the GRIFFIN study of daratumumab plus lenalidomide, bortezomib, and dexamethasone for people with newly diagnosed multiple myeloma
FUTURE ONCOLOGY
IF2.6
2024-10-250
OAAI
Voorhees, Peter M.; Sborov, Douglas W.; Laubach, Jacob; Kaufman, Jonathan L.; Reeves, Brandi; Rodriguez, Cesar; Silbermann, Rebecca; Costa, Luciano J.; Anderson, Larry D.; Nathwani, Nitya; Shah, Nina; Bumma, Naresh; Efebera, Yvonne A.; Holstein, Sarah A.; Costello, Caitlin; Jakubowiak, Andrzej; Wildes, Tanya M.; Orlowski, Robert Z.; Shain, Kenneth H.; Cowan, Andrew J.; Dinner, Shira; Gries, Katharine S.; Pei, Huiling; Cortoos, Annelore; Patel, Sharmila; Lin, Thomas S.; Usmani, Saad Z.; Richardson, Paul G.
Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm

无进展生存期作为骨髓瘤临床试验的替代终点: 一个不断发展的范式

BLOOD CANCER JOURNAL
IF11.6
2024-08-121
OAAI
Pawlyn, Charlotte; Schjesvold, Fredrik H.; Cairns, David A.; Wei, L. J.; Davies, Faith; Nadeem, Omar; Abdulhaq, Haifaa; Mateos, Maria-Victoria; Laubach, Jacob; Weisel, Katja; Ludwig, Heinz; Rajkumar, S. Vincent; Sonneveld, Pieter; Jackson, Graham; Morgan, Gareth; Richardson, Paul G.
Daratumumab in transplant-eligible patients with newly diagnosed multiple myeloma: final analysis of clinically relevant subgroups in GRIFFIN
BLOOD CANCER JOURNAL
IF11.6
2024-07-080
OAAI
Chari, Ajai; Kaufman, Jonathan L.; Laubach, Jacob; Sborov, Douglas W.; Reeves, Brandi; Rodriguez, Cesar; Silbermann, Rebecca; Costa, Luciano J.; Anderson Jr, Larry D.; Nathwani, Nitya; Shah, Nina; Bumma, Naresh; Holstein, Sarah A.; Costello, Caitlin; Jakubowiak, Andrzej; Wildes, Tanya M.; Orlowski, Robert Z.; Shain, Kenneth H.; Cowan, Andrew J.; Pei, Huiling; Cortoos, Annelore; Patel, Sharmila; Lin, Thomas S.; Voorhees, Peter M.; Usmani, Saad Z.; Richardson, Paul G.

研究方向

暂未获取到该数据
P
Paul G. Richardson
H 指数:170论文数:2,063被引数:13.1万
K
Kenneth C. Anderson
H 指数:199论文数:3,076被引数:16.7万
N
Nikhil C. Munshi
H 指数:152论文数:1,583被引数:9.5万
N
Noopur Raje
H 指数:102论文数:1,025被引数:4.4万
I
Irene M. Ghobrial
H 指数:99论文数:1,117被引数:4.5万
P
Philippe Moreau
H 指数:159论文数:2,293被引数:10.7万
O
Omar Nadeem
H 指数:23论文数:271被引数:2,138
J
Jonathan L. Kaufman
H 指数:58论文数:576被引数:1.7万
S
Saad Z. Usmani
H 指数:85论文数:1,145被引数:3.9万
A
Andrew J. Yee
H 指数:39论文数:319被引数:6,248